1H NMR and UPLC-MSE Statistical Heterospectroscopy:: Characterization of drug metabolites (xenometabolome) in epidemiological studies

被引:55
作者
Crockford, Derek J. [1 ]
Maher, Anthony D.
Ahmadi, Kourosh R.
Barrett, Amy
Plumb, Robert S.
Wilson, Ian D.
Nicholson, Jeremy K. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Div Surg Oncol Reprod Med & Anaesthet, London SW7 2AZ, England
关键词
D O I
10.1021/ac801075m
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Statistical HeterospectroscopY (SHY) is a statistical strategy for the coanalysis of multiple spectroscopic data sets acquired in parallel on the same samples. This method operates through the analysis of the intrinsic covariance between signal intensities in the same and related molecular fingerprints measured by multiple spectroscopic techniques across cohorts of samples. Here, the method is applied to 600-MHz H-1 NMR and UPLC-TOF-MSE data obtained from human urine samples (n = 86) from a subset of an epidemiological population unselected for any relevant phenotype or disease factor. We show that direct cross-correlation of spectral parameters, viz. chemical shifts from NMR and m/z data from MS, together with fragment analysis from MSE scans, leads not only to the detection of numerous endogenous urinary metabolites but also the identification of drug metabolites that are part of the latent use of drugs by the population. We show previously unreported positive mode ions of ibuprofen metabolites with their NMR correlates and suggest the detection of new metabolites of disopyramide in the population samples. This approach is of great potential value in the description of population xenometabolomes and in population pharmacology studies, and indeed for drug metabolism studies in general.
引用
收藏
页码:6835 / 6844
页数:10
相关论文
共 49 条
[1]  
Albert K, 1999, HRC-J HIGH RES CHROM, V22, P135
[2]  
BAILLIE TA, 1989, J PHARMACOL EXP THER, V249, P517
[3]  
BALES JR, 1985, CLIN CHEM, V31, P757
[4]  
BALES JR, 1984, CLIN CHEM, V30, P1631
[5]   MSE with mass defect filtering for in vitro and in vivo metabolite identification [J].
Bateman, Kevin P. ;
Castro-Perez, Jose ;
Wrona, Mark ;
Shockcor, John P. ;
Yu, Kate ;
Oballa, Renata ;
Nicoll-Griffith, Deborah A. .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2007, 21 (09) :1485-1496
[6]   Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts [J].
Beckonert, Olaf ;
Keun, Hector C. ;
Ebbels, Timothy M. D. ;
Bundy, Jacob G. ;
Holmes, Elaine ;
Lindon, John C. ;
Nicholson, Jeremy K. .
NATURE PROTOCOLS, 2007, 2 (11) :2692-2703
[7]   Insights into the mechanism of action of platinum anticancer drugs from multinuclear NMR spectroscopy [J].
Berners-Price, Susan J. ;
Ronconi, Luca ;
Sadler, Peter J. .
PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY, 2006, 49 (01) :65-98
[8]   STUDIES OF URINARY METABOLITES OF 2-(4-ISOBUTYLPHENYL)PROPIONIC ACID BY GAS-LIQUID CHROMATOGRAPHY MASS SPECTROMETRY [J].
BROOKS, CJW ;
GILBERT, MT .
JOURNAL OF CHROMATOGRAPHY, 1974, 99 (NOV6) :541-551
[9]   The application of high performance liquid chromatography, coupled to nuclear magnetic resonance spectroscopy and mass spectrometry (HPLC-NMR-MS), to the characterisation of ibuprofen metabolites from human urine [J].
Clayton, E ;
Taylor, S ;
Wright, B ;
Wilson, ID .
CHROMATOGRAPHIA, 1998, 47 (5-6) :264-270
[10]   Statistical total correlation spectroscopy:: An exploratory approach for latent biomarker identification from metabolic 1H NMR data sets [J].
Cloarec, O ;
Dumas, ME ;
Craig, A ;
Barton, RH ;
Trygg, J ;
Hudson, J ;
Blancher, C ;
Gauguier, D ;
Lindon, JC ;
Holmes, E ;
Nicholson, J .
ANALYTICAL CHEMISTRY, 2005, 77 (05) :1282-1289